Stock Earnings

Question 1

Telix Pharmaceuticals Ltd의 주요 재무제표는 무엇인가요?

Accepted Answer

최신 재무제표(Form-10K)에 따르면, Telix Pharmaceuticals Ltd의 총 자산은 $983이며, 순profit입니다.

Question 2

TLPPF의 주요 재무 비율은 무엇인가요?

Accepted Answer

Telix Pharmaceuticals Ltd의 유동비율은 1.6이고, 순이익률은 6.31, 주당 매출은 $1.46입니다.

Question 3

Telix Pharmaceuticals Ltd의 매출은 부문 또는 지역별로 어떻게 나뉘나요?

Accepted Answer

Telix Pharmaceuticals Ltd largest revenue segment is Precision Medicine, at a revenue of 771,106,000 in the most earnings release.For geography, United States is the primary market for Telix Pharmaceuticals Ltd, at a revenue of 762,308,000.

Question 4

Telix Pharmaceuticals Ltd은 수익성이 있나요?

Accepted Answer

yes, 최신 재무제표에 따르면 Telix Pharmaceuticals Ltd의 순profit은 $32입니다.

Question 5

Telix Pharmaceuticals Ltd에 부채가 있나요?

Accepted Answer

yes, Telix Pharmaceuticals Ltd의 부채는 614입니다.

Question 6

Telix Pharmaceuticals Ltd의 발행 주식은 몇 주인가요?

Accepted Answer

Telix Pharmaceuticals Ltd의 총 발행 주식은 334.72주입니다.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	662	507	325	103	7	5
Revenue Growth (YoY)	27%	56%	216%	1,371%	40%	67%
Cost of Revenue	304	194	122	42	2	2
Gross Profit	357	313	203	61	5	3
Selling, General & Admin	168	128	86	56	46	24
Research & Development	153	126	83	52	34	23
Operating Expenses	329	262	192	120	81	38
Other Non Operating Income (Expenses)	-26	-19	-8	-4	-5	0
Pretax Income	9	36	2	-63	-80	-47
Income Tax Expense	-1	3	-1	3	0	-3
Net Income	10	32	3	-67	-80	-44
Net Income Growth	-74%	967%	-104%	-16%	82%	63%
Shares Outstanding (Diluted)	337.2	345.18	323.71	310.64	282.2	257.27
Shares Change (YoY)	3%	7%	4%	10%	10%	10%
EPS (Diluted)	0.02	0.09	0.01	-0.21	-0.28	-0.17
EPS Growth	-75%	802%	-105%	-24%	64%	46%
Free Cash Flow	-23	-3	8	-50	-60	1
Free Cash Flow Per Share	-0.06	0	0.02	-0.16	-0.21	0
Gross Margin	53.92%	61.73%	62.46%	59.22%	71.42%	60%
Operating Margin	4.07%	10.05%	3.38%	-56.31%	-1,085.71%	-700%
Profit Margin	1.51%	6.31%	0.92%	-65.04%	-1,142.85%	-880%
Free Cash Flow Margin	-3.47%	-0.59%	2.46%	-48.54%	-857.14%	20%
EBITDA	--	--	--	-53	-71	-31
EBITDA Margin	--	--	--	-51.45%	-1,014.28%	-620%
D&A For EBITDA	--	--	--	5	5	4
EBIT	27	51	11	-58	-76	-35
EBIT Margin	4.07%	10.05%	3.38%	-56.31%	-1,085.71%	-700%
Effective Tax Rate	-11.11%	8.33%	-50%	-4.76%	0%	6.38%

Telix Pharmaceuticals Ltd (TLPPF) Price

TLPPF Stock Price Chart

TLPPF Income

Follow-Up Questions